Toxicity and survival by sex in patients with advanced non-small cell lung carcinoma (NSCLC) on modern Southwest Oncology Group (SWOG) trials
Albain K, Unger J, Gotay C, Davies A, Edelman M, Herbst R, Kelly K, Williamson S, Wozniak A, Gandara D. Toxicity and survival by sex in patients with advanced non-small cell lung carcinoma (NSCLC) on modern Southwest Oncology Group (SWOG) trials. Journal Of Clinical Oncology 2007, 25: 7549-7549. DOI: 10.1200/jco.2007.25.18_suppl.7549.Peer-Reviewed Original ResearchNon-small cell lung carcinomaAdvanced non-small cell lung carcinomaModern chemotherapy eraAge 60Chemotherapy eraPrognostic factorsEstrogen levelsToxicity profileBetter survivalSouthwest Oncology Group trialKaplan-Meier survival estimatesMaximum toxicity gradePatients age 60Cox multivariate modelRisk of deathCell lung carcinomaNumber of toxicitiesWomen age 60Clinical trial literatureSex-related changesEligible patientsNSCLC trialsSurvival benefitChemotherapy prescriptionsRecent trials